Stents Market Introduction and Overview
According to SPER market research, ‘Stents Market Size- By Product, By Material, By End Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Stents Market is predicted to reach 21.68 billion by 2034 with a CAGR of 3.95%.
A medical device called a stent is used to maintain the opening of a blocked passage. It serves as a tiny conduit that helps different body organs get blood and other fluids again. Both plastic and metal can be used to make stents. Stents are used to remove blockages in larger arteries; they are sometimes called the largest stents. To help clogged arteries close, drugs are applied to it. In order to prevent aneurysms from rupturing blood vessels like the brain, aorta, or others, stents are also used.
Restraints:The expansion of the stents sector may be hampered by several issues. The main obstacle is the expensive cost of stent treatments, which may limit patient access, particularly in underdeveloped countries. This high cost is often associated with the intricacy of the processes and the advanced technologies used in drug-eluting stents. Patients and healthcare providers may be discouraged from selecting stent treatments due to worries about the potential risks and adverse effects of stent implantation.
Scope of the Report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Product, By Material, By End Use.
Regions covered
North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
Companies Covered
Abbott Laboratories, B. Braun Melsungen AG, BD, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, Stryker, Terumo Corporation, W.L Gore & Associates, and Others.
Stents Market Segmentation:
By Product:Based on the Product, Global Stents Market is segmented as; Coronary Stents, Peripheral Stents, Stent Related Implant.
By Material:Based on the Material, Global Stents Market is segmented as; Metallic Biomaterial, Polymer Biomaterial, Natural Biomaterial.
By End User:Based on the End Use, Global Stents Market is segmented as; Hospital, Ambulatory Surgical Centers, Others.
By Region:This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Global Stents Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Stents Market
- 7. Global Stents Market, By Product (USD Million) 2021-2034
- 7.1. Coronary Stents
- 7.1.1. Drug-eluting stents (DES)
- 7.1.2. Bare-metal coronary stents
- 7.1.3. Bioabsorbable stents
- 7.2. Peripheral Stents
- 7.2.1. Iliac stent
- 7.2.2. Femoral-popliteal stents
- 7.2.3. Renal & related stents
- 7.2.4. Carotid stents
- 7.3. Stent Related Implant
- 7.3.1. Synthetic grafts
- 7.3.2. Vena cava filters
- 8. Global Stents Market, By Material (USD Million) 2021-2034
- 8.1. Metallic Biomaterial
- 8.2. Polymer Biomaterial
- 8.3. Natural Biomaterial
- 9. Global Stents Market, By End User (USD Million) 2021-2034
- 9.1. Hospital
- 9.2. Ambulatory Surgical Centers
- 9.3. Others
- 10. Global Stents Market (USD Million) 2021-2034
- 10.1. Global Stents Market Size and Market Share
- 11. Global Stents Market, By Region, (USD Million) 2021-2034
- 11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
- 11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
- 11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
- 11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
- 11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America
- 12. Company Profile
- 12.1. Abbott Laboratories
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. B. Braun Melsungen AG
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. BD
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Biosensors International Group, Ltd.
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. Biotronik SE & Co. KG
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Boston Scientific Corporation
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. Elixir Medical Corporation
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Medtronic Plc
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Meril Life Science
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. MicroPort Scientific Corporation
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Stryker
- 12.11.1. Company details
- 12.11.2. Financial outlook
- 12.11.3. Product summary
- 12.11.4. Recent developments
- 12.12. Terumo Corporation
- 12.12.1. Company details
- 12.12.2. Financial outlook
- 12.12.3. Product summary
- 12.12.4. Recent developments
- 12.13. W.L Gore & Associates
- 12.13.1. Company details
- 12.13.2. Financial outlook
- 12.13.3. Product summary
- 12.13.4. Recent developments
- 12.14. Others
- 13. Conclusion
- 14. List of Abbreviations
- 15. Reference Links
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook